CEO Foster buys $1M in CRL stock; COO Girshick buys $250K

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CEO James Foster purchased 6,075 shares at avg $165.01 (~$1M); COO Girshick purchased 1,514 shares at avg $164.63 (~$250K) on Feb 20, 2025.
Both terminated existing Rule 10b5-1 trading plans on Feb 19 to allow purchases without violating Section 16 short-swing profit rules.
Foster's plan allowed up to 129,721 shares; he sold 25,000 shares under it in Aug 2024. Girshick's plan allowed up to 22,362 shares; no sales occurred.
Executives cited confidence in strategic direction and long-term growth prospects as reason for open-market purchases.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.